APNA, AANA issue statement on ketamine infusion therapy

Two national nursing associations have issued a joint statement recognizing that ketamine infusion therapy may benefit patients with psychiatric disorders, including major depressive disorder, bipolar disorder, treatment-resistant depression, and post-traumatic stress disorder. The statement acknowledges the therapy's increasing use for these conditions.

Study at a glance

Abstract

Observing that ketamine infusion therapy is increasingly being used for such mental health conditions as major depressive disorder, bipolar disorder, treatment‐resistant depression, and post‐traumatic stress disorder, two national nursing associations have released a joint statement indicating that patients with psychiatric disorders may benefit from the use of ketamine infusion therapy.